Abstract
Drug-coated balloon angioplasty (DCBA) has been recognized for its utility in preventing in-stent re-restenosis (ISR); however, imaging of the neointima immediately after treatment and during follow-up has only been described in a few case reports. This study aimed to determine the efficacy and mechanism of the DCBA using imaging studies both immediately after the DCBA and during the follow-up period. We enrolled 15 consecutive patients who underwent DCBA for in-stent restenosis (ISR). The in-stent neointimal volume was evaluated using optical coherence tomography (OCT), and the in-stent yellow grade was assessed using coronary angioscopy (CAS) immediately after DCBA and during the median follow-up period of 9 (8–15) months. The neointimal volume was significantly reduced from 77.1 ± 36.2 mm3 at baseline to 60.2 ± 23.9 mm3 immediately after DCBA (p = 0.0012 vs. baseline) and to 46.7 ± 21.9 mm3 during the follow-up (p = 0.0002 vs. post DCBA). The yellow grade of the residual plaques at the ISR lesion, which indicated plaque vulnerability, was significantly decreased in the follow-up CAG (from baseline: 1.79 ± 1.03, during the follow-up: 0.76 ± 0.82; p < 0.0001). These data suggest that DCBA may inhibit neointimal formation and provide angioscopic intimal stabilization for ISR lesions.
Similar content being viewed by others
References
Radke PW, Koiser A, Frost C, Sigwart U (2003) Outcome after treatment of coronary in-stent restenosis; results from a systematic review using meta-analysis techniques. Eur Heart J 24:266–273
Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B (2015) Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. EuroIntervention 11(8):926–934
Wöhrle J, Zadura M, Möbius-Winkler S, Leschke M, Opitz C, Ahmed W, Barragan P, Simon JP, Cassel G, Scheller B (2012) SeQuentPlease World Wide Registry: clinical results of SeQuentPlease paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J Am Coll Cardiol. 60:1733–1738
Auffret V, Berland J, Barragan P, Waliszerwski M, Bonello L, Delarche N, Furber A, Albert F, Carrié D, Eltchaninoff H, Pansieri M, Schneeberger M, Piot C, Marcollet P, Bedossa M (2016) Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry. Int J Cardiol 203:690–696
Rittger H, Waliszewski M, Brachmann J, Hohenforst-Schmidt W, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Schlundt C, Zimmermann S, Lonke S, von Cranach M, Markovic S, Daniel WG, Achenbach S, Wöhrle J (2015) Long-term outcomes after treatment with a paclitaxel-coated balloon versus balloon angioplasty: Insights from the PEPCAD-DES Study (treatment of drug-eluting stent [DES] in-stent restenosis with SeQuent please paclitaxel-coated percutaneous transluminal coronary angioplasty [PTCA] catheter). JACC Cardiovasc Interv 8:1695–1700
Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B (2015) Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. EuroIntervention 11:926–934
Murata N, Takayama T, Hiro T (2017) Serial observations of in-stent restenosis treated with drug-coated balloon angioplasty by optical coference tomography and coronary angioscopy. Int Heart J. 58:134–139
Tada T, Kadota K, Hosogi S, Miyake K, Amano H, Nakamura M, Izawa Y, Kubo S, Ichinohe T, Hyoudou Y, Eguchi H, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tanaka H, Fuku Y, Kato H, Goto T, Mitsudo K (2014) Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty. Eur Heart J Cardiovasc Imaging 15:307–315
Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB (1999) Angiographic patterns of in-stent restenosis: classifyion and implications for lomg-term outcome. Circulation 100:1872–1878
Mehanna EA, Attizzani GF, Kyono H, Hake M, Bezerra HG (2011) Aessessment of coronary stent by optical coherence tomography, methodology and definitions. Int J Cardiovasc Imaging 27:259–269
Hirayama A, Saito S, Ueda Y, Takayama T, Honye J, Komatsu S, Yamaguchi O, Li Y, Yajima J, Nanto S, Takazawa K, Kodama K (2009) Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. Circ J 73:718–725
Ueda Y, Asakura M, Yamaguchi O, Hirayama A, Hori M, Kodama K (2001) The healing processs of infarct-related plaques: insights from 18 months of serial angioscopic follow-up. J Am Coll Cardiol 38:1916–1922
Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia HM, van Soest G, van der Giessen W, Regar E (2009) Optical coherence tomogramphy patterns of stent restenosis. Am Heart J 158:284–293
Tanimoto S, Aoki J, Serruys PW, Regar E (2006) Paclitaxel-eluting stent restenosis shows three-layer appearance by optical coherence tomogramphy. Eurointervention 1:484
Masawa T, Abe S, Toyoda S, Sakuma M, Nasuno T, Kageyama M, Tokura M, Koizumi S, Taguchi I, Inoue T (2016) Comparison of the performance of zotarolimus- and everolimus-eluting stents by optical coherence tomography and coronary angioscopy. Heart Vessels 31:1230–1238
Kodama K, Komatsu S, Ueda Y, Takayama T, Yajima J, Nanto S, Matsuoka H, Saito S, Hirayama A (2010) Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound—the TOGETHER trial. Circ J 74:1922–1928
Scheller B, Clever YP, Kelsh B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Speck U, Böhm M, Cremers B (2012) Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv 5:323–330
Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B (2015) Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. EuroIntervention 11:926–934
Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, Brugger A, Thiele H, Birkemever R, Kurowski V, Breithardt OA, Schmidt M, Zimmermann S, Lonke S, von Cranach M, Nguyen TV, Daniel WG, Wöhrle J (2012) A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 59:1377–1382
Caplow M, Shanks J, Ruhlen R (1994) How taxol modulates microtubule disassembly. J Biol Chem 269:23399–23402
Bhat N, Perera PY, Carboni JM, Blanco J, Golenbock DT, Mayadas TN, Vogel SN (1999) Use of a photoactivatable taxol analog to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role of Mac-1 in taxol-induced gene expression. J Immunol 162:7335–7342
Jun CD, Choi BM, Kim HM, Chung HT (1995) Involvement of protein kinase C during taxol-induced activation of murine peritoneal macrophages. J Immunol 154:6541–6547
Tada T, Kadota K, Hosogi S, Miyakw K, Ohya M, Amano H, Izawa Y, Kanazawa T, Kubo S, Ichinohe T, Hyoudou Y, Hayakawa Y, Sabbah MM, Otsuru S, Hasegawa D, Habara S, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K (2015) Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervenetion for in-stent restenosis lesions: a compareson between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation. Eur Heart J Cardiovasc Imaging 16:1101–1111
Shibuya M, Ishihara M (2016) Coronary angioscopy for the evaluation of vessel response after drug-eluting stent implantation. Circ J 80:590–591
Ishihara T, Awata M, Sera F, Fujita M, Watanabe T, Iida O, Ishida Y, Nanto S, Uematsu M (2013) Arterial repair 4 months after zotarolimus-eluting stent implantation observed on angioscopy. Circ J 77:1186–1192
Sotomi Y, Suzuki S, Kobayashi T, Hamanaka Y, Nakatani S, Hirata A, Takeda Y, Ueda Y, Sakata Y, Higuchi Y (2018) Impact of the 1-year angioscopic findings on long-term clinical events in 504 patients treated with first-generation or second generation drug-eluting stents : the DESNOTE-X study. EuroIntervention. https://doi.org/10.4244/EIJ-D-18-00660
Takayama T, Hiro T, Ueda Y, Honye J, Komatsu S, Yamaguchi O, Li Y, Yajima J, Takazawa K, Nanto S, Saito S, Hirayama A, Kodama K (2013) Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-Serial angioscopic and intravascular ultrasound analysis. J Cardiol 61:381–386
Suzuki T, Suzuki T, Hosokawa H (1998) Comparison of the restenosismechanism of cutting balloon angioplasty and plain old balloon angioplasty: a serial intravascular ultrasound study (abstract) J Am Coll Cardiol 31: 498.
Tsukahara R, Muramatsu T, Akimoto N (1996) Mechanism of acute gain and late loss operating in angioplasty with a cutting balloon as evaluated by intravascular ultrasonography. Jpn J Interv Cardiol 11:439–442
Acknowledgements
The authors would like to extend their sincere appreciation to Professor Atsushi Hirayama for guidance and valuable suggestions during the research, to Professor Yasuo Okumura and Professor Tadateru Takayama for their direct guidance during the research. Furthermore, we would like to express our gratitude to the catheter room of Nihon University Itabashi Hospital, who always cooperated at the clinical site of the research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Hirayama A and Hiro T are employed by the Department of Advanced Cardiovascular Imaging, Nihon University School of Medicine; which is endowed by Boston Scientific Corporation Japan, Abbott Medical Japan Co., Ltd and St. Jude Medical Japan Co., Ltd.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study and its protocols were approved by the Institutional Review Board of Nihon University Itabashi Hospital. This article does not contain any studies with animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Akutsu, N., Ogaku, A., Koyama, Y. et al. Effect of drug-coated balloon angioplasty on in-stent restenotic coronary lesions analyzed with optical coherence tomography and serial coronary artery angioscopy. Heart Vessels 34, 1925–1935 (2019). https://doi.org/10.1007/s00380-019-01447-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-019-01447-5